Acrivon Therapeutics, Inc. 8-K
Accession 0001193125-25-197250
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:25 PM ET
Size
33.8 MB
Accession
0001193125-25-197250
Documents
- 8-Kacrv-20250905.htmPrimary
8-K
- EX-99.1acrv-ex99_1.htm
EX-99.1
- GRAPHICacrv-ex99_1s1.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s2.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s3.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s4.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s5.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s6.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s7.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s8.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s9.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s10.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s11.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s12.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s13.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s14.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s15.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s16.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s17.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s18.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s19.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s20.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s21.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s22.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s23.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s24.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s25.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s26.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s27.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s28.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s29.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s30.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s31.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s32.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s33.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s34.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s35.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s36.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s37.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s38.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s39.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s40.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s41.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s42.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s43.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s44.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s45.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s46.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s47.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s48.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s49.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s50.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s51.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s52.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s53.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s54.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s55.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s56.jpg
GRAPHIC
- GRAPHICacrv-ex99_1s57.jpg
GRAPHIC
- EX-101.SCHacrv-20250905.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-197250-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLacrv-20250905_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Related Parties
1- filerCIK 0001781174
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:25 PM ET
- Size
- 33.8 MB